HENRY F. STOLL, M.D., F.A.C.P.; HENRY P. HOPKINS, M.D.; JOHN C. MARTIN, M.D.
The correct appraisal of a new therapeutic measure is always difficult and in a disease presenting as many variables as pneumonia, it is particularly so. Not only does the mortality vary in different years but it is influenced by the age of the patient, the type of pneumococcus, the presence of complications and especially by the duration of the disease before the treatment is begun. Accordingly, no final opinion as to the value of any treatment can be arrived at until a large group of treated cases is compared with a similar untreated group. Our series is so small that
STOLL HF, HOPKINS HP, MARTIN JC. THE TREATMENT OF LOBAR PNEUMONIA BY ARTIFICIAL PNEUMOTHORAX: A STUDY OF TWENTY-FIVE CASES1. Ann Intern Med. ;8:1611–1624. doi: 10.7326/0003-4819-8-12-1611
Download citation file:
Published: Ann Intern Med. 1935;8(12):1611-1624.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use